International Journal of Nephrology and Renal Disorders (IJNRD) is a peer-reviewed open access journal that publishes all type of articles related to nephrology and renal disorders. The journal covers various topics such as acute kidney injury, chronic kidney disease, dialysis, transplantation, and other related conditions. The journal aims to provide a platform for researchers, clinicians, and medical professionals to publish their work and share their knowledge and experience in the field of nephrology and renal disorders. The journal also seeks to promote awareness and understanding of renal disorders and their management.
Plagiarism Policy
IJNRD follows strict plagiarism rules, the submitted article must contain a minimum of 70–80% unique content. The article undergoes multiple revisions if it is plagiarised to make sure the content is unique, and it helps the author improve their research as we have an expert Editorial Board.
Peer Review Process
IJNRD undergoes a double-blind peer review process that takes 7–10 days, we also have a fast-track peer review process.
You can submit your article online or through email at elisaeditor123@gmail.com
International Journal of Nephrology and Renal Disorders is an invaluable resource committed to the advancement and dissemination of research in the field of nephrology and renal disorders. It aims to provide comprehensive coverage of all aspects of nephrology, including but not limited to metabolic and endocrine alterations, cardiovascular diseases, transplantation, hypertension, chronic and acute kidney diseases, acute renal failure, dialysis, and immunology. The journal also highlights the importance of health-related policies, programs, and initiatives in the prevention, management, and treatment of renal disorders. The primary goal of IJNRD is to advance the understanding, prevention, diagnosis, and treatment of all diseases and disorders related to the kidneys.
The journal encourages authors to submit their research in any of the following areas: clinical nephrology, epidemiology of renal diseases, epidemiology of kidney transplantation, immunopathology and immunogenetics of nephropathies, kidney transplantation, laboratory nephrology, molecular genetics in renal diseases, the pathophysiology of renal diseases, renal pharmacology, and renal toxicology.
Related topics:
Acute kidney injury (AKI) |
Nephrology |
Alport syndrome |
Nephron |
Bartter syndrome |
Nephropathy |
Chronic kidney disease (CKD) |
Nephrotic syndrome |
Creatinine clearance |
Paediatric Nephrology |
Cystitis |
Pathophysiology of Renal Diseases |
Diabetic Nephropathy |
Pediatric Nephrology |
Diagnosis Treatment & Medical Procedures |
Peritoneal dialysis |
Dialysis |
Polycystic kidney disease |
Dialysis hemodialysis |
Proteinuria |
Electrolyte balance |
Pyelonephritis |
Electrolyte imbalance |
Renal artery stenosis |
Endothelial Glycocalyx |
Renal Biology |
Fanconi syndrome |
Renal biopsy |
Genetics of Renal Diseases |
Renal calculi |
Gitelman syndrome |
Renal cell carcinoma |
Glomerulonephritis |
Renal cysts |
Glomerulus |
Renal disease |
Hematuria |
Renal Failure |
Hemodialysis |
Renal function |
Hydronephrosis |
Renal Immunology |
Hyper uraemia |
Renal impairment |
Hypertension |
Renal Medicine |
Hypertensive nephropathy |
Renal medicine |
IgA nephropathy |
Renal osteodystrophy |
Interstitial nephritis |
Renal Pharmacology |
Kidney |
Renal Replacement Therapy |
Kidney disease |
Renal stones |
Kidney Diseases or Nephropathy |
Renal tract |
Kidney function |
Renal transplantation |
Kidney Functions |
Renal tubular acidosis |
Kidney nephrology |
Renal tubules |
Kidney stones |
Transplantation |
Kidney Transplantation |
Treatment for Kidney Diseases |
Kidneys: Physiology & Functions |
Uremia |
Lupus nephritis |
Ureteropelvic junction obstruction |
Membranous nephropathy |
Urinary tract infection (UTI) |
Minimal change disease |
Vasculitis |
Nephritis |
Vesicoureteral Reflux |
Before submission of manuscript to the journal, kindly check the below mentioned guidelines
Authors Information
All persons who qualify for authorship should be listed as authors. However, the corresponding author must ensure that each author listed has substantially contributed or participated sufficiently in the work and is responsible for that particular portion of the manuscript. However, people who do not qualify for authorship should be listed in acknowledgments.
Submission Format
Submissions to Pubtexto journals should include the following:
Authors are encouraged to submit all the components as \'zip file\' while submitting on our online system or via email as an attachment.
Cover Letter should:
Manuscript Layout
The word count for original research is 3500–4000 words and up to 5500 words for studies involving meta-analysis. Authors are encouraged to employ a standard and concise writing style. If you are not a native English speaker, we encourage you to utilize our language editing services-or ask a native English speaking colleague for assistance.
Title: The title should not exceed 200 characters and set in title case. The title should be concise, specific, and easily comprehensible to readers.
Abstract: The abstract should not exceed 300 words and may or may not be unstructured (without sub-heading such as objective, methodology, results, discussion, etc.). It should provide a clear description of the objective(s) of the study, demonstrate the methodology used, and summarize the study\'s prime conclusion(s). In the end, a statement regarding the study\'s significance to a potentially wider audience should be included.
Keywords: Authors can provide 4-6 keywords. The first letter of each keyword should be upper case, and keywords should be separated by a semicolon (;)
Main Text
Introduction
The introduction should set the tone of the paper by providing a clear statement of the study, the relevant literature on the study subject and the proposed approach or solution. The introduction should be general enough to attract a reader\'s attention from a broad range of scientific disciplines.
Materials and methods
This section should provide a complete overview of the design of the study. Detailed descriptions of materials or participants, comparisons, interventions, and types of analysis should be mentioned. However, only new procedures should be described in detail; previously published procedures should be cited and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer\'s name and address.
Results and Discussion
The results section should provide complete details of the experiment that are required to support the conclusion of the study. The results should be written in the past tense when describing findings in the authors\' experiments. Previously published findings should be written in the present tense. Results and discussion may be combined or in a separate section. Speculation and detailed interpretation of data should not be included in the results but should be put into the discussion section.
Conclusion:
This section should provide to adhere to support the study conclusions. This section included briefly detailed conclusive parameters of the whole study.
Acknowledgments:
This should include all the people who have contributed toward the work in one way or the other. However, authors are required to ensure that people acknowledged should agree to be so named.
Funding Information
List all the sources of funding, including relevant research grant numbers, as applicable. Also, authors are encouraged to list all the contributing authors associated with specific funding, if applicable.
Optional information
While we are not obligated to use these or recommend to the concerned Editor(s), we do encourage authors to provide names and contact information of 2-4 external reviewers and, if applicable, 1-2 opposed reviewers.
References
Published work along with any citable items should be cited in the reference list. While we follow very stringent reference formats, authors need not to spend time formatting their reference. They can submit the manuscripts formatted in any reference style (style will be formatted once the manuscript is accepted for publication), but it is preferable that they adhere to the journal format.
Reference format:
Pubtexto uses the following style. Items are listed numerically in the order they are cited in the text.
Example journal article (2-6 authors): Salwachter AR, Freischlag JA, Sawyer RG, Sanfey HA, Fukushima H, Cureoglu. The training needs and priorities of male and female surgeons and their trainees. J Am Coll Surg. 2005; 201: 199-205.
Example journal article (more than 6 authors): Fukushima H, Cureoglu S, Schachern P, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg. 2005; 133: 100-6.
Example book: Modlin J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the United States. San Francisco, CA: Pediatric Academic Societies; 2004.
Example book chapter: Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585-606.
Example online article: Wolf W. State\'s mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:1B
Example article from any database: Calhoun D, Trimarco T, Meek R, Locasto D. Distinguishing diabetes: Differentiate between type 1 & type 2 DM. JEMS [serial online]. November 2011; 36(11):32-48. Available from: CINAHL Plus with Full Text, Ipswich, MA. Accessed February 2, 2012.
In-text citation: For referencing an article, a number is used. This is different from in-text citations in AMA—author\'s last name is not used. The order of numbering will be contingent on the order in which you use that reference within your paper. For example, the first article referenced will be given number one in superscript (1) followed by the second and third articles as 2,3. In the references section, the articles should appear numerically in the order they are cited within the text.
Figures and Tables
Figures and tables should be included in the main text (manuscript) to aid in the review process. However, for larger files (size exceeding 10 Mb) must always be submitted separately (should be properly mentioned in the main text, wherever applicable).
Figure captions and legends
Figure files should be included in the main document, and not as supplemental materials. Figure caption should be preceded by the figure, while figure legends should immediately follow the figure. Figure captions should be concise (not to exceed 18 words) and set in bold type. All figures should be numbered in sequence, using Arabic numerals, for example, Figure 1, Figure 2, etc.
Table captions and legends
Tables should be cited in ascending numeric order. Each table should be preceded by a table caption (brief and specific; not to exceed 18 words), and immediately followed by table legends, if applicable, used to explain abbreviations and other supporting information about the data. Larger tables, however, can be submitted as supplemental materials.
Review Comments and Revision
Submission Instructions
While submitting a revised manuscript, the authors should include the following:
Revised manuscript (clean copy): Prepare a clean copy of your revised manuscript that does not show track changes. Rename this file as \"Main Document\".
Revised manuscript (marked-up copy): Include a copy of your manuscript file showing the changes you have made (track changes). Rename this file as \"Manuscript with Track Changes\".
Response to reviewers: Address the specific points made by each Reviewer and/or Editor. Include your responses to all the reviewers\' and editor\'s comments and list the changes you have made to the manuscript. Rename this file as "Response to Reviewers".
Supplementary Information
Information integral to the comprehensive understanding of the manuscript, but is either too large to be included in the main document or due to any other reason, should be submitted as support materials, such as 3-D visualizations, interactive graphics, large tables and/or figures, and so on. However, authors should note that normal figures and tables should not be included under supplemental materials.
Ethical Guidelines
For manuscripts reporting medical studies that involve human or animal subjects, the ethics committee that approved the study must be identified in the manuscript. For studies involving human subjects, all work must conform to the recognized standards as per the \"Declaration of Helsinki\". In case of any experiments involving animals, authors must provide a declaration that all measures were taken to avoid animal suffering at each stage and also must furnish a detailed description of the procedures used.
Patient Consent
In manuscripts reporting patient cases, patient anonymity must be preserved. Case reports submitted to Pubtexto Publications should conform to the International Committee of Medical Journal Editors\' (ICMJE) recommendations. Patient privacy should be taken care of, and personally, identifiable information should not be revealed without informed consent. If informed consent has been obtained, the details must be mentioned in the manuscript.
For live patients, signed consent is mandatory if the authors wish to reveal the patient\'s identity. In the case of deceased patients, consent must be taken from the patient\'s next of kin. If a patient\'s consent was not obtained, the patient\'s details should be anonymized as much as possible. Patient\'s photographs need to be cropped sufficiently to prevent the revelation of identity.
Authors are not required to submit the copy of the patient\'s consent while submitting their manuscript for consideration in Pubtexto Publications. However, they should confirm in the Cover Letter that the patient\'s consent has been obtained. In certain instances, the Editorial Office might request the authors to provide a copy of the same.
Medicine: Int J Nephrol Ren Disord 2022, 1: 1
Medicine: Int J Nephrol Ren Disord 2022, 1: 1
Medicine: Int J Nephrol Ren Disord 2022, 1: 1
Medicine: Int J Nephrol Ren Disord 2022, 1: 1
Medicine: Int J Nephrol Ren Diosrd 2023, 2: 1
Medicine: Int J Nephrol Ren Diosrd 2023, 2: 1
Medicine: Int J Nephrol Ren Diosrd 2023, 2: 1
Medicine: Int J Nephrol Ren Diosrd 2024, 3: 1